TherapeuticsMD, Inc. is a U.S.-based pharmaceutical company dedicated to women's health. Its marketed portfolio includes IMVEXXY, prescribed for moderate to severe dyspareunia; ...
IMVEXXY is a FDA-approved, ultra-low-dose vaginal estradiol softgel capsule specifically designed to treat moderate to severe dyspareunia (painful intercourse), which is a common symptom of vulvar and vaginal atrophy due to menopause.
Price Range: Prescription pricing varies by insurance coverage and pharmacy.
Pain Points: Painful intercourse and discomfort associated with menopause-related vaginal atrophy.
Solutions: Provides localized hormonal relief with a lower systemic absorption profile compared to traditional hormone therapies.
Target Users: Post-menopausal women experiencing vaginal dryness and pain during intercourse.
BIJUVA is an FDA-approved oral hormone replacement therapy that combines bio-identical 17β-estradiol and bio-identical progesterone in a single capsule to treat moderate to severe vasomotor symptoms (hot flashes) associated with menopause.
Price Range: Prescription pricing varies by insurance coverage and pharmacy.
Pain Points: Vasomotor symptoms (hot flashes) that disrupt quality of life and sleep.
Solutions: Combines two hormones in one pill to reduce symptoms while minimizing potential side effects compared to non-bio-identical synthetic alternatives.
Target Users: Menopausal women with an intact uterus seeking relief from hot flashes.
ANNOVERA is a procedure-free, patient-controlled vaginal ring that provides contraception for up to one year. It delivers a combination of segesterone acetate (a progestin) and ethinyl estradiol.
Price Range: Prescription pricing varies by insurance coverage and pharmacy.
Pain Points: The need for daily, weekly, or monthly dosing common in other contraceptives; reduces the hassle of frequent medical appointments.
Catalent Pharma Solutions (now Novo Holdings subsidiary)API and excipient suppliers to Catalent (various)Silicone polymer and hormone API suppliers for ANNOVERA
Downstream
6
Mayne Pharma Group LimitedASX:MYXTheramex HQ UK LimitedKnight Therapeutics Inc.TSX:GUDAmneal Pharmaceuticals, Inc.NASDAQ:AMRXDuchesnay Inc.Population Council
